Recently, lysophosphatidylcholine acyltransferase 1 (LPCAT1), a lipid metabolic enzyme, was reported to be overexpressed and to function as a tumor-promoting role in several types of cancers, such as prostate cancer, gastric cancer, and liver cancer 10-12. This evidence concerns the gene LPCAT1 and Familial prostate cancer.